Collegium Pharmaceutical, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Collegium Pharmaceutical, Inc. (COLL) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$5.32 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2015-08-12
- Collegium Pharmaceutical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2015-06-30 was -$5.32M.
- Collegium Pharmaceutical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2015-03-31 was -$4.93M.
- Collegium Pharmaceutical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2014-06-30 was -$4.94M.
- Collegium Pharmaceutical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2014-03-31 was -$4.59M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month |
|---|---|---|
| 2015-06-30 | -$5.32M 10-Q · filed 2015-08-12 | -$1.14M 10-Q · filed 2015-08-12 |
| 2015-03-31 | -$4.93M 10-Q/A · filed 2015-07-17 | |
| 2014-06-30 | -$4.94M 10-Q · filed 2015-08-12 | -$9.53M 10-Q · filed 2015-08-12 |
| 2014-03-31 | -$4.59M 10-Q/A · filed 2015-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |